A groundbreaking “Multispeciality National Consensus on Hypertension in Women: New Frontiers” (MNC.HTN.W) was convened at Hotel Taj Mansingh in New Delhi on Tuesday.
The event, organised by the American Association of Cardiologists of Indian Origin (AACIO), International Society of Cardiovascular Ultrasound (ISCU), World Heart Academy, and World Wellness Foundation, in partnership with JB Chemical Pharmaceutical Limited, was the first of its kind globally.
The consensus focused on enhancing the clinical management of hypertension in women through a comprehensive cardio-renal-metabolic approach. Dr. H.K. Chopra, Organizing Chairman and National President, highlighted the urgent need for effective hypertension management, citing alarming statistics. He noted that India faces a significant burden of hypertension, with prevalence rates soaring as high as 80% in individuals aged 80 and above. Dr. Chopra emphasised that uncontrolled hypertension is akin to a "global tsunami," causing premature heart attacks, strokes, and other severe complications.
Data from the Indian Council of Medical Research (ICMR) and the World Health Organization (WHO) revealed that 90% of Indians with hypertension remain uncontrolled, a statistic of grave concern. Dr. Chopra stressed that hypertension management must begin early and involve a combination of lifestyle changes and medication to prevent severe health issues.
Dr. Tiny Nair of Trivandrum discussed the risks associated with hypertensive diseases of pregnancy (HDP), including long-term cardiovascular risks. He emphasised the importance of recognising HDP as a risk factor for future heart disease and advocated for comprehensive care strategies.
Dr. Viveka Kumar from Delhi spoke on resistant hypertension, noting its challenges and the importance of lifestyle changes and personalised treatment plans. Dr. Sarita Rao from Indore highlighted the need for aggressive treatment strategies, including combination therapies to manage hypertension effectively.
Dr. Arpita Ray Chaudhury from Kolkata pointed out the rising prevalence of hypertension among younger adults and stressed the importance of early intervention and effective medication like cilnidipine.
Vikas Khare, Vice President of JB Chemical Pharmaceutical Limited, underscored the importance of gender-specific approaches in hypertension care.
The conference also featured the “Annual Accolades Ceremony for Women,” honouring over 100 prominent female doctors for their contributions to advanced medical care. The ceremony recognised these women for their dedication to improving healthcare outcomes and empowering women in the medical field.
